Chen H, Zuo Q, Wang Y, Song J, Yang H, Zhang Y, et al. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters. BMC Biotechnol. 2017;17:11 pubmed publisher

Kele M, Day K, Rönnholm H, Schuster J, Dahl N, Falk A. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions. Stem Cell Res. 2016;17:474-478 pubmed publisher

Umrath F, Steinle H, Weber M, Wendel H, Reinert S, Alexander D, et al. Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA. Int J Mol Sci. 2019;20: pubmed publisher

Rodriguez Gutierrez D, Eid W, Biason Lauber A. A Human Gonadal Cell Model From Induced Pluripotent Stem Cells. Front Genet. 2018;9:498 pubmed publisher

Pane L, Fulcoli F, Cirino A, Altomonte A, Ferrentino R, Bilio M, et al. Tbx1 represses Mef2c gene expression and is correlated with histone 3 deacetylation of the anterior heart field enhancer. Dis Model Mech. 2018;11: pubmed publisher

Shafa M, Yang F, Fellner T, Rao M, Baghbaderani B. Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. Front Med (Lausanne). 2018;5:69 pubmed publisher

Parmar V, Parmar T, Arai E, Perusek L, Maeda A. A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells. Stem Cell Res. 2018;27:95-104 pubmed publisher

Kong T, Park J, Jang J, Kim C, Bae S, Choi Y, et al. Immunomodulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke. Exp Mol Med. 2018;50:e425 pubmed publisher

Verma N, Pan H, Dore L, Shukla A, Li Q, Pelham Webb B, et al. TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat Genet. 2018;50:83-95 pubmed publisher

Chen X, Janssen J, Liu J, Maggio I, t Jong A, Mikkers H, et al. In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat Commun. 2017;8:657 pubmed publisher

Shukla V, Rao M, ZHANG H, Beers J, Wangsa D, Wangsa D, et al. ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer. Cancer Res. 2017;77:6267-6281 pubmed publisher

Kotini A, Chang C, Chow A, Yuan H, Ho T, Wang T, et al. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell. 2017;20:315-328.e7 pubmed publisher

Luo Y, Zhu D. Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy. Biomed Res Int. 2014;2014:751397 pubmed publisher

Ginsberg M, James D, Ding B, Nolan D, Geng F, Butler J, et al. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGF? suppression. Cell. 2012;151:559-75 pubmed publisher